ILUSTRASI. Several generic drugmakers that will produce versions of Pfizer's Covid-19 antiviral treatment Paxlovid have agreed to sell the medicine in low- and middle-income countries for US$ 25 a course or less. REUTERS/Dado Ruvic/Illustration//File Photo
Sumber: Reuters | Editor: Anastasia Lilin Yuliantina
KONTAN.CO.ID - NEW YORK. Several generic drugmakers that will produce versions of Pfizer's Covid-19 antiviral treatment Paxlovid have agreed to sell the medicine in low- and middle-income countries for US$ 25 a course or less. The Clinton Health Access Initiative (CHAI) said on Thursday.
CHAI said it could not disclose the names of the manufacturers who have agreed to the price ceiling. Because, they are still in the early stage of product development and have not received regulatory approval.
Agar bisa lanjut membaca sampai tuntas artikel ini, pastikan Anda sudah berlangganan atau membeli artikel ini.
Sudah berlangganan? Masuk
Berlangganan Hanya dengan 20rb/bulan Anda bisa mendapatkan berita serta analisis ekonomi, bisnis, dan investasi pilihan
Business Insight, Epaper Harian + Tabloid, Arsip Epaper 30 Hari
Gratis uji coba 7 hari pertama. Anda dapat menggunakan akun Google sebagai metode pembayaran.
